Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

ADMA Biologics, Inc.

NASDAQ: ADMAHealthcare / Biotechnology / USA
4.62-0.0600-1.28%Vol 612 9871Y Perf -2.33%
Apr 18th, 2019 16:00
BID4.51 ASK4.65
Open4.64 Previous Close4.68
Pre-Market4.65 After-Trading4.62
 -0.03 -0.64%  - -%
Target Price
11.46 
Analyst Rating
Strong Buy 1.25
Potencial %
148.05 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
★+     40.76
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)214 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
52.05 
Earnings Date
13th May 2019

Today's Price Range

4.474.70

 

52wk Range

2.086.96

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Neutral
Performance
1 Month
16.37%
3 Months
37.50%
6 Months
-16.46%
1 Year
-2.33%
3 Years
-38.56%
5 Years
-42.25%

Name / TickerPriceChg.Chg.%
ADMA4.62-0.0600-1.28
AAPL203.860.73000.36
GOOG1 236.370.03000.00
MSFT123.371.60001.31
XOM81.13-0.3000-0.37
WFC47.580.03000.06
JNJ137.52-1.0000-0.72
FB178.28-0.5000-0.28
GE9.350.23002.52
JPM113.46-0.8400-0.73
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
2.50
Current Ratio
4.60
Long Term Debt to Total Capital
0.69
Total Debt to Equity
2.24
Interest Coverage
-10.90
Leverage Ratio 2.90
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-148.40
EBIT Margin
-354.50
EBITDA Margin
-334.30
Pre-tax Profit Margin
-272.80
Profit Margin
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
12 979
Revenue per Share
0.28
Revenue Growth 3 Years
31.34
Revenue Growth 5 Years
36.05

Earnings HistoryEstimateReportedSurprise %
Q04 2018-0.33-0.39-18.18
Q03 2018-0.33-0.330.00
Q02 2018-0.32-0.35-9.38
Q01 2018-0.27-0.35-29.63
Q04 2017-0.51-0.2452.94
Q03 2017-0.510.59215.69
Q02 2017-0.42-0.55-30.95
Q01 2017-0.22-0.51-131.82
Earnings Per EndEstimateRevision %Trend
3/2019 QR-0.31-55.00Negative
6/2019 QR-0.32-88.24Negative
12/2019 FY-1.14-103.57Negative
12/2020 FY-0.58-514.29Negative
Next Report Date13th May 2019
Estimated EPS Next Report-0.32
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume612 987
Shares Outstanding (in ths.)46 353
Trades Count2 207
Dollar Volume2 638 433
Avg. Volume991 653
Avg. Weekly Volume894 682
Avg. Monthly Volume2 336 335
Avg. Quarterly Volume1 131 055

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

45%55%

Bearish Bullish

56%44%

Bearish Bullish

54%46%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
1 (25.00 %)
1 (20.00 %)
1 (20.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.25
Strong Buy
1.20
Strong Buy
1.20

There are no comments yet.

News